UBP43 in Hematopoiesis
UBP43 in Hematopoiesis
批准号:
8318588
负责人:
DONG-ER ZHANG
金额:
$38.24万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-15 至 2015-08-31
关键词:
AddressAnemiaBacterial InfectionsBlood CellsCell Differentiation processCell ProliferationCellsComplexDefectDeubiquitinating EnzymeDiseaseFamilyGenerationsGoalsHematopoiesisHematopoieticHematopoietic stem cellsInfectionInterferon Type IInterferonsMolecularMusPeptide HydrolasesPhosphorylationPost-Translational Protein ProcessingProcessProteinsRegulationRoleSignal PathwaySignal TransductionStressTestingTranscriptional RegulationUbiquitin Like ProteinsVirus Diseasesabstractingbiological adaptation to stressblood treatmentenzyme activityinsightmembernovelpathogenprogenitorresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The long-term goal of this study is to understand the function of ubp43 (usp18) in
hematopoiesis. Hematopoiesis is a complex process of cell proliferation and differentiation.
Regulation of hematopoiesis occurs at multiple levels including transcriptional regulation, signal
transduction, and protein modification. We cloned a novel member of the deubiquitinating enzyme
family, termed ubp43. Further studies have demonstrated that ubp43 is a protease that specifically
removes the ubiquitin like protein ISG15 from protein conjugates. Like phosphorylation, ISGylation
is a mechanism of protein modification. However, in contrast to phosphorylation, only a limited
understanding exists of the mechanisms and consequences of ISGylation. Interferons strongly
induce ubp43 expression. Ubp43 deficient mice have fundamental differences in their
hematopoietic response to interferons. Furthermore, ubp43 deficient hematopoietic cells have
significantly enhanced type I interferon signaling. Most importantly, ubp43 has deconjugating
enzyme activity dependent and independent functions in interferon signal transduction. This
proposal tests the hypothesis that ubp43 is crucial for hematopoiesis under stress conditions, such
as viral and bacterial infections and genotoxic insults, by interacting with critical factors in
hematopoiesis and in the JAK-STAT signaling pathway and by regulating the level of protein
ISGylation. The studies proposed in Specific Aim #1 will characterize ubp43 enzyme activity in
hematopoiesis. The studies proposed in Specific Aim #2 will investigate the molecular mechanism
of inhibition of type I interferon signaling by ubp43. The studies proposed in Specific Aim #3 will
study the role of ubp43 in hematopoietic stem cells and progenitors. The experiments proposed
will address fundamental questions about ubp43 in hematopoiesis during stress responses, which
may provide valuable insight into the treatment of blood related diseases. Project Narrative
Blood cell formation is tightly regulated at different levels in the response to various
stimulations. Ubp43 is highly increased in blood cells upon pathogen infection, interferon
treatment, and other stresses. Understand of its role in blood cells may help to develop novel
therapies to treat defects in blood cell generation and function, such as anemia and infections.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/emmm.201201864
发表时间:
2013-07
期刊:
EMBO MOLECULAR MEDICINE
影响因子:
11.1
作者:
[Burkart, Christoph, Arimoto, Kei-ichiro, Tang, Tingdong, Cong, Xiuli, Xiao, Nengming, Liu, Yun-Cai, Kotenko, Sergei V., Ellies, Lesley G., Zhang, Dong-Er]
通讯作者:
Zhang, Dong-Er
DOI:
10.1016/j.bbrc.2012.05.154
发表时间:
2012-06-29
期刊:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子:
3.1
作者:
[Yim, Hwa Young, Yang, Young, Lim, Jong-Seok, Lee, Myeong Seok, Zhang, Dong-Er, Kim, Keun Il]
通讯作者:
Kim, Keun Il
DOI:
10.4049/jimmunol.1101609
发表时间:
2012-05-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Cong XL, Lo MC, Reuter BA, Yan M, Fan JB, Zhang DE]
通讯作者:
Zhang DE
DOI:
10.1038/ni.2169
发表时间:
2012-01-01
期刊:
NATURE IMMUNOLOGY
影响因子:
30.5
作者:
[Honke, Nadine, Shaabani, Namir, Lang, Karl S.]
通讯作者:
Lang, Karl S.
USP18 in Cancer Development
-
批准号:10596566
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2019
-
负责人:DONG-ER ZHANG
-
依托单位:
USP18 in Cancer Development
-
批准号:9886213
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2019
-
负责人:DONG-ER ZHANG
-
依托单位:
USP18 in Cancer Development
-
批准号:10377534
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2019
-
负责人:DONG-ER ZHANG
-
依托单位:
USP18 in Cancer Development
-
批准号:10132268
-
项目类别:
-
资助金额:$37.82万
-
财政年份:2019
-
负责人:DONG-ER ZHANG
-
依托单位:
CSF2 receptor mediated actions in t(8;21) leukemia
-
批准号:9014529
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2015
-
负责人:DONG-ER ZHANG
-
依托单位:
CSF2 receptor mediated actions in t(8;21) leukemia
-
批准号:8842430
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2015
-
负责人:DONG-ER ZHANG
-
依托单位:
Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
-
批准号:10400021
-
项目类别:
-
资助金额:$62.03万
-
财政年份:2013
-
负责人:DONG-ER ZHANG
-
依托单位:
ISG15 and protein ISGylation in Cancer
-
批准号:8616739
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2013
-
负责人:DONG-ER ZHANG
-
依托单位:
ISG15 and protein ISGylation in Cancer
-
批准号:8535417
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2013
-
负责人:DONG-ER ZHANG
-
依托单位:
Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
-
批准号:9922899
-
项目类别:
-
资助金额:$64.18万
-
财政年份:2013
-
负责人:DONG-ER ZHANG
-
依托单位:
ISG15 and Protein ISGylation in Cancer
-
批准号:10116297
-
项目类别:
-
资助金额:$41.43万
-
财政年份:2013
-
负责人:DONG-ER ZHANG
-
依托单位:
ISG15 and Protein ISGylation in Cancer
-
批准号:10590733
-
项目类别:
-
资助金额:$40.51万
-
财政年份:2013
-
负责人:DONG-ER ZHANG
-
依托单位:
ISG15 and protein ISGylation in Cancer
-
批准号:9002027
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2013
-
负责人:DONG-ER ZHANG
-
依托单位:
ISG15 and Protein ISGylation in Cancer
-
批准号:10360673
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2013
-
负责人:DONG-ER ZHANG
-
依托单位:
International RUNX Workshop
-
批准号:8129107
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2011
-
负责人:DONG-ER ZHANG
-
依托单位:
SEARCH AML1-ETO INTERACTING PROTEIN
-
批准号:8171272
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2010
-
负责人:DONG-ER ZHANG
-
依托单位:
UBP43 in Hematopoiesis
-
批准号:7919940
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2008
-
负责人:DONG-ER ZHANG
-
依托单位:
SEARCH AML1-ETO INTERACTING PROTEIN
-
批准号:7723659
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2008
-
负责人:DONG-ER ZHANG
-
依托单位:
UBP43 in Hematopoiesis
-
批准号:7687335
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2008
-
负责人:DONG-ER ZHANG
-
依托单位:
UBP43 in Hematopoiesis
-
批准号:8134424
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2008
-
负责人:DONG-ER ZHANG
-
依托单位:
国内基金
海外基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
-
批准号:82302715
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:熊泽康
-
依托单位:
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:陈英伟
-
依托单位:
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
-
批准号:31200592
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:孙伟力
-
依托单位: